Identification of small molecule inhibitors that distinguish between non-transferrin bound Iron uptake and transferrin-mediated iron transport

Chemistry and Biology

Volumn 11, Issue 3, 2004, Pages 407-416

  Brown, Jing Xu ^a   Buckett, Peter D ^a   Wessling Resnick, Marianne ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; IRON; TRANSFERRIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HELA CELL; HUMAN; IC 50; METABOLISM; MOLECULAR WEIGHT; SPECTROFLUOROMETRY; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; DRUG EVALUATION, PRECLINICAL; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; IRON; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFERRIN;

MAMMALIA;

EID: 6444230040     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.02.016     Document Type: Article

References (56)

1. Specht K.M., Shokat K.M. The emerging power of chemical genetics. Curr. Opin. Cell Biol. 14:2002;155-159.
2. Stockwell B.R. Frontiers in chemical genetics. Trends Biotechnol. 18:2000;449-455.
3. Stockwell B.R. Chemical genetics. ligand-based discovery of gene function Nat. Rev. Genet. 1:2000;116-125.
4. Lingrel J.B., Kuntzweiler T. Na+,K(+)-ATPase. J. Biol. Chem. 269:1994;19659-19662.
5. Carter S.B. Effects of cytochalasins on mammalian cells. Nature. 213:1967;261-264.
6. Benos D.J. Amiloride. a molecular probe of sodium transport in tissues and cells Am. J. Physiol. 242:1982;C131-C145.
7. Schwartz A., Grupp G., Wallick E., Grupp I.L., Ball W.J. Jr. Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides. Prog. Clin. Biol. Res. 268B:1988;321-338.
8. Wardzala L.J., Cushman S.W., Salans L.B. Mechanism of insulin action on glucose transport in the isolated rat adipose cell. Enhancement of the number of functional transport systems. J. Biol. Chem. 253:1978;8002-8005.
9. Czech M.P. Characterization of (3H)cytochalasin B binding to the fat cell plasma membrane. J. Biol. Chem. 251:1976;2905-2910.
10. Carter-Su C., Pessin J.E., Mora R., Gitomer W., Czech M.P. Photoaffinity labeling of the human erythrocyte D-glucose transporter. J. Biol. Chem. 257:1982;5419-5425.
11. Sariban-Sohraby S., Benos D.J. Detergent solubilization, functional reconstitution, and partial purification of epithelial amiloride-binding protein. Biochemistry. 25:1986;4639-4646.
12. Kleyman T.R., Yulo T., Ashbaugh C., Landry D., Cragoe E. Jr., Karlin A., Al-Awqati Q. Photoaffinity labeling of the epithelial sodium channel. J. Biol. Chem. 261:1986;2839-2843.
13. Barbry P., Chassande O., Vigne P., Frelin C., Ellory C., Cragoe E.J. Jr., Lazdunski M. Purification and subunit structure of the [3H]phenamil receptor associated with the renal apical Na+ channel. Proc. Natl. Acad. Sci. USA. 84:1987;4836-4840.
14. Lingrel J.B., Arguello J.M., Van Huysse J., Kuntzweiler T.A. Cation and cardiac glycoside binding sites of the Na,K-ATPase. Ann. N Y Acad. Sci. 834:1997;194-206.
15. Inukai K., Asano T., Katagiri H., Anai M., Funaki M., Ishihara H., Tsukada K., Kikuchi M., Yazaki Y., Oka Y. Replacement of both tryptophan residues at 388 and 412 completely abolished cytochalasin B photolabelling of the GLUT1 glucose. Biochem. J. 302:1994;355-361.
16. Garcia J.C., Strube M., Leingang K., Keller K., Mueckler M.M. Amino acid substitutions at tryptophan 388 and tryptophan 412 of the HepG2 (Glut1) glucose transporter inhibit transport activity and targeting to the plasma membrane in Xenopus oocytes. J. Biol. Chem. 267:1992;7770-7776.
17. Gutierrez J.A., Wessling-Resnick M. Molecular mechanisms of iron transport. Crit. Rev. Eukaryot. Gene Expr. 6:1996;1-14.
18. Nunez M.T., Gaete V., Watkins J.A., Glass J. Mobilization of iron from endocytic vesicles. The effects of acidification and reduction. J. Biol. Chem. 265:1990;6688-6692.
19. Watkins J.A., Nunez M.T., Gaete V., Alvarez O., Glass J. Kinetics of iron passage through subcellular compartments of rabbit reticulocytes. J. Membr. Biol. 119:1991;141-149.
20. Oshiro S., Nakajima H., Markello T., Krasnewich D., Bernardini I., Gahl W.A. Redox, transferrin-independent, and receptor-mediated endocytosis iron uptake systems in cultured human fibroblasts. J. Biol. Chem. 268:1993;21586-21591.
21. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., Andrews N.C. Nramp2 is mutated in the anemic Belgrade (b) rat. evidence of a role for Nramp2 in endosomal iron transport Proc. Natl. Acad. Sci. USA. 95:1998;1148-1153.
22. Fleming M.D., Trenor C.C. 3rd, Su M.A., Foernzler D., Beier D.R., Dietrich W.F., Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16:1997;383-386.
23. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
24. Bowen B.J., Morgan E.H. Anemia of the Belgrade rat. evidence for defective membrane transport of iron Blood. 70:1987;38-44.
25. Edwards J.A., Sullivan A.L., Hoke J.E. Defective delivery of iron to the developing red cell of the Belgrade laboratory rat. Blood. 55:1980;645-648.
26. Farcich E.A., Morgan E.H. Diminished iron acquisition by cells and tissues of Belgrade laboratory rats. Am. J. Physiol. 262:1992;R220-R224.
27. Farcich E.A., Morgan E.H. Uptake of transferrin-bound and nontransferrin-bound iron by reticulocytes from the Belgrade laboratory rat. comparison with Wistar rat transferrin and reticulocytes Am. J. Hematol. 39:1992;9-14.
28. Garrick M.D., Gniecko K., Liu Y., Cohan D.S., Garrick L.M. Transferrin and the transferrin cycle in Belgrade rat reticulocytes. J. Biol. Chem. 268:1993;14867-14874.
29. Su M.A., Trenor C.C., Fleming J.C., Fleming M.D., Andrews N.C. The G185R mutation disrupts function of the iron transporter Nramp2. Blood. 92:1998;2157-2163.
30. Gruenheid S., Canonne-Hergaux F., Gauthier S., Hackam D.J., Grinstein S., Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J. Exp. Med. 189:1999;831-841.
31. Wessling-Resnick M. Iron transport. Annu. Rev. Nutr. 20:2000;129-151.
32. Inman R.S., Wessling-Resnick M. Characterization of transferrin- independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J. Biol. Chem. 268:1993;8521-8528.
33. Simpson R.J., Peters T.J. Studies of Fe3+ transport across isolated intestinal brush-border membrane of the mouse. Biochim. Biophys. Acta. 772:1984;220-226.
34. Sturrock A., Alexander J., Lamb J., Craven C.M., Kaplan J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J. Biol. Chem. 265:1990;3139-3145.
35. Barisani D., Berg C.L., Wessling-Resnick M., Gollan J.L. Evidence for a low Km transporter for non-transferrin-bound iron in isolated rat hepatocytes. Am. J. Physiol. 269:1995;G570-G576.
36. Kaplan J., Jordan I., Sturrock A. Regulation of the transferrin- independent iron transport system in cultured cells. J. Biol. Chem. 266:1991;2997-3004.
37. Morgan E.H. Membrane transport of non-transferrin-bound iron by reticulocytes. Biochim. Biophys. Acta. 943:1988;428-439.
38. Gutteridge J.M., Rowley D.A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci. (Lond.). 68:1985;463-467.
39. Batey R.G., Lai Chung Fong, P., Shamir, S., and Sherlock, S. A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 25:1980;340-346.
40. Cabantchik Z.I., Glickstein H., Milgram P., Breuer W. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal. Biochem. 233:1996;221-227.
41. Zanninelli G., Glickstein H., Breuer W., Milgram P., Brissot P., Hider R.C., Konijn A.M., Libman J., Shanzer A., Cabantchik Z.I. Chelation and mobilization of cellular iron by different classes of chelators. Mol. Pharmacol. 51:1997;842-852.
42. Breuer W., Epsztejn S., Millgram P., Cabantchik I.Z. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. 268:1995;1354-1361.
43. Breuer W., Epsztejn S., Cabantchik Z.I. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270:1995;24209-24215.
44. Staubli A., Boelsterli U.A. The labile iron pool in hepatocytes. prooxidant-induced increase in free iron precedes oxidative cell injury Am. J. Physiol. 274:1998;1031-1037.
45. Pinero D.J., Hu J., Cook B.M., Scaduto R.C. Jr., Connor J.R. Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim. Biophys. Acta. 1497:2000;279-288.
46. Schonhorn J.E., Akompong T., Wessling-Resnick M. Mechanism of transferrin receptor down-regulation in K562 cells in response to protein kinase C activation. J. Biol. Chem. 270:1995;3698-3705.
47. Schonhorn J.E., Wessling-Resnick M. Brefeldin A down-regulates the transferrin receptor in K562 cells. Mol. Cell. Biochem. 135:1994;159-169.
48. Hynes J., Floyd S., Soini A.E., O'Connor R., Papkovsky D.B. Fluorescence-based cell viability screening assays using water-soluble oxygen probes. J. Biomol. Screen. 8:2003;264-272.
49. Yang A., Cardona D.L., Barile F.A. In vitro cytotoxicity testing with fluorescence-based assays in cultured human lung and dermal cells. Cell Biol. Toxicol. 18:2002;97-108.
50. Greger R. Chloride channel blockers. Methods Enzymol. 191:1990;793-810.
51. Tunnicliff G., Smith J.A. Competitive inhibition of gamma-aminobutyric acid receptor binding by N-2-hydroxyethylpiperazine-N'-2-e-ethanesulfonic acid and related buffers. J. Neurochem. 36:1981;1122-1126.
52. Matheson G.K., Freed E., Tunnicliff G. Novel GABA analogues as hypotensive agents. Neuropharmacology. 25:1986;1191-1195.
53. Davis-Kaplan S.R., Askwith C.C., Bengtzen A.C., Radisky D., Kaplan J. Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p. an unexpected role for intracellular chloride channels Proc. Natl. Acad. Sci. USA. 95:1998;13641-13645.
54. Ponka P., Borova J., Neuwirt J., Fuchs O., Necas E. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents. Biochim. Biophys. Acta. 586:1979;278-297.
55. Ponka P., Borova J., Neuwirt J., Fuchs O. Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent. FEBS Lett. 97:1979;317-321.
56. Nick H., Wong A., Acklin P., Faller B., Jin Y., Lattmann R., Sergejew T., Hauffe S., Thomas H., Schnebli H.P. ICL670a. preclinical profile Adv. Exp. Med. Biol. 509:2002;185-203.